Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000819050-21-000132
Filing Date
2021-08-12
Accepted
2021-08-12 16:16:32
Documents
55
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q bbi-20210630.htm   iXBRL 10-Q 1137914
2 EX-10.1 a2021063010qex101.htm EX-10.1 50450
3 EX-10.4 a2021063010qex104.htm EX-10.4 26056
4 EX-31.1 a2021063010qex311.htm EX-31.1 10113
5 EX-31.2 a2021063010qex312.htm EX-31.2 9842
6 EX-32.1 a2021063010qex321.htm EX-32.1 8913
  Complete submission text file 0000819050-21-000132.txt   4490333

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bbi-20210630.xsd EX-101.SCH 32698
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bbi-20210630_cal.xml EX-101.CAL 36134
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bbi-20210630_def.xml EX-101.DEF 143542
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bbi-20210630_lab.xml EX-101.LAB 381803
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bbi-20210630_pre.xml EX-101.PRE 242697
12 EXTRACTED XBRL INSTANCE DOCUMENT bbi-20210630_htm.xml XML 535791
Mailing Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301
Business Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301 (720) 505-4755
Brickell Biotech, Inc. (Filer) CIK: 0000819050 (see all company filings)

EIN.: 930948554 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21088 | Film No.: 211167780
SIC: 2836 Biological Products, (No Diagnostic Substances)